This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Tax lots affect cost basis and gains in retirement accounts. This piece compares ETFs and mutual funds to help you choose.
25,093 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Analysts boosted targets on UNFI and MTDR after solid quarterly results, signaling renewed investor optimism as pipel...
Major cryptocurrencies hold support as regulatory and macro headlines shape momentum. The crypto price prediction tod...
Northrop Grumman shares are rising on a new Air Force contract to speed up B-21 production, signaling upside not yet ...
A new collaboration between Uber and Amazon's Zoox signals more than tech sharing. This alliance could redefine the e...
Wedbush boosts its Micron price target to $500, arguing demand remains healthy after the Chinese New Year. The upgrad...
Washington eyes a softer Basel III endgame, freeing up about $175B in excess bank capital. Crypto markets are watchin...
Is chipotle stock long-term buy? This guide breaks down growth engines, risks, and a clear framework to decide if CMG...
Broadcom is reshaping its AI compute position beyond hardware. This analysis outlines a plausible path for Broadcom's...
A gripping court filing alleges a spouse exploited surveillance and a seed phrase to drain a vast Bitcoin stash. This...
CrowdStrike forms a strategic tie-up with Nebius Group to integrate Falcon security into Nebius AI Cloud, while repor...
Bitcoin hovers near $74,000 as market eyes Powell and the Fed. An analyst warns of a repeat sell-the-news pattern, ev...